GMAB logo

Genmab A/S (GMAB) Cash from financing

annual CFF:

-$568.60M-$480.62M(-546.27%)
December 31, 2024

Summary

  • As of today (May 22, 2025), GMAB annual cash flow from financing activities is -$568.60 million, with the most recent change of -$480.62 million (-546.27%) on December 31, 2024.
  • During the last 3 years, GMAB annual CFF has fallen by -$501.77 million (-750.81%).
  • GMAB annual CFF is now -203.61% below its all-time high of $548.79 million, reached on December 31, 2019.

Performance

GMAB Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGMABcash flow metrics

quarterly CFF:

-$1.83M-$11.22M(-119.52%)
March 1, 2025

Summary

  • As of today (May 22, 2025), GMAB quarterly cash flow from financing activities is -$1.83 million, with the most recent change of -$11.22 million (-119.52%) on March 1, 2025.
  • Over the past year, GMAB quarterly CFF has increased by +$10.55 million (+85.20%).
  • GMAB quarterly CFF is now -100.34% below its all-time high of $541.62 million, reached on September 30, 2019.

Performance

GMAB quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGMABcash flow metrics

TTM CFF:

-$558.06M+$10.55M(+1.86%)
March 1, 2025

Summary

  • As of today (May 22, 2025), GMAB TTM cash flow from financing activities is -$558.06 million, with the most recent change of +$10.55 million (+1.86%) on March 1, 2025.
  • Over the past year, GMAB TTM CFF has dropped by -$545.81 million (-4455.82%).
  • GMAB TTM CFF is now -200.97% below its all-time high of $552.68 million, reached on March 31, 2020.

Performance

GMAB TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGMABcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

GMAB Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-546.3%+85.2%-4455.8%
3 y3 years-750.8%+81.0%-1267.1%
5 y5 years-203.6%-182.8%-201.0%

GMAB Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-750.8%at low-114.4%+99.6%-4455.8%+3.9%
5 y5-year-203.6%at low-114.4%+99.6%-201.0%+3.9%
alltimeall time-203.6%at low-100.3%+99.6%-201.0%+3.9%

GMAB Cash from financing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$1.83M(-119.5%)
-$558.06M(-1.9%)
Dec 2024
-$568.60M(+546.3%)
$9.39M(-118.2%)
-$568.60M(-2.1%)
Sep 2024
-
-$51.71M(-89.9%)
-$580.69M(+10.4%)
Jun 2024
-
-$513.90M(+4050.7%)
-$525.99M(+4194.0%)
Mar 2024
-
-$12.38M(+358.7%)
-$12.25M(-86.1%)
Dec 2023
-$87.98M(-21.3%)
-$2.70M(-190.2%)
-$87.98M(+21.2%)
Sep 2023
-
$2.99M(-1943.0%)
-$72.58M(-54.7%)
Jun 2023
-
-$162.40K(-99.8%)
-$160.33M(-15.8%)
Mar 2023
-
-$88.11M(-793.6%)
-$190.31M(+70.1%)
Dec 2022
-$111.85M(+67.4%)
$12.70M(-115.0%)
-$111.85M(-8.5%)
Sep 2022
-
-$84.75M(+181.2%)
-$122.26M(+281.1%)
Jun 2022
-
-$30.14M(+212.2%)
-$32.08M(-21.4%)
Mar 2022
-
-$9.65M(-521.1%)
-$40.82M(-38.9%)
Dec 2021
-$66.83M(-714.3%)
$2.29M(-57.7%)
-$66.83M(+4.1%)
Sep 2021
-
$5.42M(-114.0%)
-$64.21M(-3.4%)
Jun 2021
-
-$38.88M(+9.0%)
-$66.48M(+146.2%)
Mar 2021
-
-$35.66M(-826.5%)
-$27.00M(-348.2%)
Dec 2020
$10.88M(-98.0%)
$4.91M(+55.2%)
$10.88M(+1.4%)
Sep 2020
-
$3.16M(+434.8%)
$10.73M(-98.0%)
Jun 2020
-
$591.50K(-73.3%)
$549.19M(-0.6%)
Mar 2020
-
$2.21M(-53.5%)
$552.68M(+0.7%)
Dec 2019
$548.79M(-4979.5%)
$4.76M(-99.1%)
$548.79M(+0.9%)
Sep 2019
-
$541.62M(>+9900.0%)
$544.11M(>+9900.0%)
Jun 2019
-
$4.08M(-343.8%)
$4.86M(-40.5%)
Mar 2019
-
-$1.67M(-2297.0%)
$8.17M(-172.6%)
Dec 2018
-$11.25M(-134.4%)
$76.20K(-96.8%)
-$11.25M(-2.2%)
Sep 2018
-
$2.38M(-67.8%)
-$11.50M(+19.5%)
Jun 2018
-
$7.39M(-135.0%)
-$9.62M(+204.6%)
Mar 2018
-
-$21.09M(>+9900.0%)
-$3.16M(-109.7%)
Dec 2017
$32.73M(+141.5%)
-$181.60K(-104.3%)
$32.73M(-10.6%)
Sep 2017
-
$4.26M(-69.3%)
$36.63M(+23.0%)
Jun 2017
-
$13.85M(-6.4%)
$29.77M(+31.3%)
Mar 2017
-
$14.80M(+298.0%)
$22.67M(+67.3%)
Dec 2016
$13.55M
$3.72M(-243.3%)
$13.55M(-17.4%)
Sep 2016
-
-$2.59M(-138.4%)
$16.41M(-56.1%)
Jun 2016
-
$6.76M(+19.0%)
$37.41M(-29.8%)
DateAnnualQuarterlyTTM
Mar 2016
-
$5.67M(-13.7%)
$53.32M(-44.3%)
Dec 2015
$95.67M(-48.2%)
$6.58M(-64.2%)
$95.67M(+2.6%)
Sep 2015
-
$18.40M(-18.8%)
$93.24M(+31.0%)
Jun 2015
-
$22.66M(-52.8%)
$71.19M(+43.5%)
Mar 2015
-
$48.03M(+1058.1%)
$49.63M(-73.1%)
Dec 2014
$184.67M(+583.8%)
$4.15M(-213.7%)
$184.67M(-5.2%)
Sep 2014
-
-$3.65M(-432.3%)
$194.81M(-2.8%)
Jun 2014
-
$1.10M(-99.4%)
$200.46M(-2.2%)
Mar 2014
-
$183.07M(+1181.3%)
$205.03M(+659.2%)
Dec 2013
$27.01M(-56.3%)
$14.29M(+610.8%)
$27.01M(-64.1%)
Sep 2013
-
$2.01M(-64.5%)
$75.26M(+3.0%)
Jun 2013
-
$5.66M(+12.2%)
$73.04M(+8.8%)
Mar 2013
-
$5.04M(-91.9%)
$67.11M(+8.6%)
Dec 2012
$61.79M(-5530.8%)
$62.54M(<-9900.0%)
$61.79M(-6143.2%)
Sep 2012
-
-$206.00K(-24.0%)
-$1.02M(-6.6%)
Jun 2012
-
-$271.00K(-0.1%)
-$1.09M(-3.0%)
Mar 2012
-
-$271.40K(-1.0%)
-$1.13M(-0.8%)
Dec 2011
-$1.14M(-8.8%)
-$274.10K(-1.5%)
-$1.14M(-4.7%)
Sep 2011
-
-$278.30K(-8.6%)
-$1.19M(-2.0%)
Jun 2011
-
-$304.60K(+8.4%)
-$1.22M(+3.4%)
Mar 2011
-
-$280.90K(-14.9%)
-$1.18M(-5.6%)
Dec 2010
-$1.25M(+0.3%)
-$329.90K(+8.9%)
-$1.25M(-1.7%)
Sep 2010
-
-$302.90K(+14.7%)
-$1.27M(-8.1%)
Jun 2010
-
-$264.00K(-24.6%)
-$1.38M(-8.7%)
Mar 2010
-
-$350.30K(-0.3%)
-$1.51M(+21.5%)
Dec 2009
-$1.24M(-125.0%)
-$351.40K(-15.2%)
-$1.24M(+39.4%)
Sep 2009
-
-$414.30K(+4.9%)
-$891.90K(+86.7%)
Jun 2009
-
-$394.90K(+377.5%)
-$477.60K(+477.5%)
Mar 2009
-
-$82.70K
-$82.70K
Dec 2008
$4.98M(-98.3%)
-
-
Dec 2007
$286.92M(+93.8%)
-
-
Dec 2006
$148.05M(+198.1%)
-
-
Dec 2005
$49.67M(-41.0%)
-
-
Dec 2004
$84.20M(<-9900.0%)
-
-
Dec 2003
-$543.60K(-102.7%)
-
-
Dec 2002
$19.96M
-
-

FAQ

  • What is Genmab A/S annual cash flow from financing activities?
  • What is the all time high annual CFF for Genmab A/S?
  • What is Genmab A/S annual CFF year-on-year change?
  • What is Genmab A/S quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Genmab A/S?
  • What is Genmab A/S quarterly CFF year-on-year change?
  • What is Genmab A/S TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Genmab A/S?
  • What is Genmab A/S TTM CFF year-on-year change?

What is Genmab A/S annual cash flow from financing activities?

The current annual CFF of GMAB is -$568.60M

What is the all time high annual CFF for Genmab A/S?

Genmab A/S all-time high annual cash flow from financing activities is $548.79M

What is Genmab A/S annual CFF year-on-year change?

Over the past year, GMAB annual cash flow from financing activities has changed by -$480.62M (-546.27%)

What is Genmab A/S quarterly cash flow from financing activities?

The current quarterly CFF of GMAB is -$1.83M

What is the all time high quarterly CFF for Genmab A/S?

Genmab A/S all-time high quarterly cash flow from financing activities is $541.62M

What is Genmab A/S quarterly CFF year-on-year change?

Over the past year, GMAB quarterly cash flow from financing activities has changed by +$10.55M (+85.20%)

What is Genmab A/S TTM cash flow from financing activities?

The current TTM CFF of GMAB is -$558.06M

What is the all time high TTM CFF for Genmab A/S?

Genmab A/S all-time high TTM cash flow from financing activities is $552.68M

What is Genmab A/S TTM CFF year-on-year change?

Over the past year, GMAB TTM cash flow from financing activities has changed by -$545.81M (-4455.82%)
On this page